Leqembi could cost Medicare up to $17.8B
(By Rylee Wilson for Becker’s Hospital Review) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease, will
Read More(By Rylee Wilson for Becker’s Hospital Review) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease, will
Read More(Source – www.cms.gov/newsroom) Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following
Read More(Source – www.cms.gov/newsroom) For the first time in history, Medicare has the ability to directly negotiate the prices of covered
Read More(By Helen Branswell for STAT) A panel of experts that advises the Centers for Disease Control and Prevention on vaccinations
Read More(By Rylee Wilson for Becker’s Hospital Review) New GLP-1 drugs to treat diabetes and obesity can be expensive, and most
Read More(Source – The Kaiser Family Foundation Published June 2023) Medicare provides health insurance coverage for more than 65 million people,
Read More(By Rylee Wilson for Becker’s Hospital Review) Medicare Part D beneficiaries that don’t receive low-income subsidies spend 2.5 times more
Read More(By Jeannie Fuglesten Biniek, Meredith Freed, Anthony Damico, and Tricia Neuman for Kaiser Family Foundation published May 01, 2023) According
Read More(Rylee Wilson for Becker’s Hospital Review) The average premium cost for Medicare Advantage plans sold on eHealth increased from $6
Read More(By Juliette Cubanski for Kaiser Family Foundation Published: Apr 20, 2023) The Inflation Reduction Act of 2022 (the Act), signed
Read More